SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-17-047931
Filing Date
2017-02-17
Accepted
2017-02-17 16:00:57
Documents
2
Group Members
LYDA HILLMALACHITE TRUST

Document Format Files

Seq Description Document Type Size
1 SC 13G d339815dsc13g.htm SC 13G 72411
2 EXHIBIT 1 d339815dex991.htm EX-99.1 4014
  Complete submission text file 0001193125-17-047931.txt   78195
Mailing Address 6200 LOOKOUT ROAD BOULDER CO 80301
Business Address 6200 LOOKOUT ROAD BOULDER CO 80301 303-531-5952
MIRAGEN THERAPEUTICS, INC. (Subject) CIK: 0001590750 (see all company filings)

IRS No.: 471187261 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88625 | Film No.: 17621313
SIC: 8071 Services-Medical Laboratories

Mailing Address 2101 CEDAR SPRINGS ROAD, SUITE 601 DALLAS TX 75201
Business Address 2101 CEDAR SPRINGS ROAD, SUITE 601 DALLAS TX 75201 (214) 506-2662
Remeditex Ventures LLC (Filed by) CIK: 0001627363 (see all company filings)

IRS No.: 452451953 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G